Giannopoulou et al. investigated the methylation status of the RASSF1A promoter in primary tumors, tumor cell-free tissues anatomically close to the tumor, and matched circulating tumor DNA (ctDNA) samples from patients with high-grade serous ovarian cancers (HGSCs). The gene discussed is RASSF1; the disease is neoplasm.